Skip to main content

Peer Review reports

From: Real-world effectiveness of intravenous belimumab in adults with systemic lupus erythematosus: results of the observational OBSErve study in the Russian Federation

Original Submission
16 Apr 2024 Submitted Original manuscript
8 Jul 2024 Reviewed Reviewer Report
11 Jul 2024 Reviewed Reviewer Report
1 Oct 2024 Author responded Author comments - Lindsey Teichman
Resubmission - Version 2
1 Oct 2024 Submitted Manuscript version 2
9 Oct 2024 Author responded Author comments - Lindsey Teichman
Resubmission - Version 3
9 Oct 2024 Submitted Manuscript version 3
15 Oct 2024 Author responded Author comments - Lindsey Teichman
Resubmission - Version 4
15 Oct 2024 Submitted Manuscript version 4
6 Dec 2024 Reviewed Reviewer Report
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
20 Dec 2024 Editorially accepted
8 Jan 2025 Article published 10.1186/s41927-024-00452-0

You can find further information about peer review here.

Back to article page